According to FutureWise analysis, the market for companion diagnostics in 2023 is US$6.83 billion, and is expected to reach US$16.22 billion by 2031 at a CAGR of 11.40%.

The global companion diagnostics market was valued at approximately USD 9.06 billion in 2024 and is projected to experience significant growth, reaching around USD 15.98 billion by 2030. This expansion is expected to achieve a robust compound annual growth rate (CAGR) of approximately 10.5% from 2025 to 2030. The primary driver of this growth is the increasing incidence of chronic conditions such as cancer, cardiovascular diseases, and autoimmune disorders. These trends are creating a heightened demand for targeted therapies, wherein companion diagnostics play a crucial role by enabling healthcare professionals to select the most effective treatments while minimizing potential adverse effects for patients. North America stands out as the leading region in this market, largely due to its advanced healthcare infrastructure and significant investment in medical research. Within this market, the largest segment comprises assays, kits, and reagents, which are essential tools for conducting precise diagnostics. Tissue-based sample testing remains the dominant approach, providing invaluable insights into disease pathology. Furthermore, cutting-edge technological advancements in next-generation sequencing (NGS), polymerase chain reaction (PCR), and digital pathology are revolutionizing the field by enhancing both diagnostic accuracy and efficiency. These innovations are not only improving patient outcomes but are also facilitating a broader application of companion diagnostics in pharmaceutical research and development pipelines, further propelling market momentum.

FutureWise Market Research has released a report that provides an in-depth analysis of Companion Diagnostics Market trends that will impact the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=9822&type=requestsample

Companion Diagnostics Market Segmentation:

By Product and Service

• Assay kits and Reagents
• Software and Services

By Technology

• Polymerase Chain Reaction (PCR)
• In Situ Hybridization (ISH)
• Next-Generation Sequencing (NGS)
• Immunohistochemistry (IHC)
• Others (Multiplex Assay and Cellular Imaging Technologies)

By Indication

• Cardiovascular
• Neurological Diseases
• Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Gastric Cancer
• Infectious Diseases
• Others (inflammatory and inherited diseases)

By End User

• Pharmaceutical and Biopharmaceutical Companies
• Reference Laboratories
• CROs
• Others (Physicians, Hospitals, Academic Medical Centers, Payers)

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Companion Diagnostics Market:

• F. HOFFMANN-LA ROCHE AG
• AGILENT TECHNOLOGIES, INC.
• QIAGEN N.V.
• THERMO FISHER SCIENTIFIC, INC.
• ABBOTT LABORATORIES, INC.
• ALMAC GROUP
• DANAHER CORPORATION
• ILLUMINA INC.
• BIOMÉRIEUX SA
• NMYRIAD GENETICS, INC.
• SYSMEX CORPORATION
• ABNOVA CORPORATION
• GUARDANT HEALTH, INC.
• ICON PLC
• BIOGENEX LABORATORIES, INC.
• INVIVOSCRIBE TECHNOLOGIES
• ARCHERDX, INC

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9822&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Companion Diagnostics Market By Product & Service, By Technology, By Indication, By End User, and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model, and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are complimentary with the purchase of any report license.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com